SPECTRACRON CLEAR TOPCOAT

Hazard statements (CLP)

H225, H315, H317, H319, H336, H341, H351, H360, H370, H372

Code

Statements

H225

Highly Flammable liquid and vapour

SECTION 2: Hazards identification

Classification of the substance or mixture FLAMMABLE LIQUIDS - Category 2 SKIN IRRITATION - Category 2 EYE IRRITATION - Category 2A SKIN SENSITIZATION - Category 1 GERM CELL MUTAGENICITY - Category 2 CARCINOGENICITY - Category 2 TOXIC TO REPRODUCTION (Fertility) - Category 1B TOXIC TO REPRODUCTION (Unborn child) - Category 1B SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) (thymus) - Category 1 SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) (Narcotic effects) - Category 3 SPECIFIC TARGET ORGAN TOXICITY (REPEATED EXPOSURE) (immune system, kidneys, liver) - Category 1 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 35.7% (Oral), 46.6% (Dermal), 48.2% (Inhalation)

Signal word

Danger

Hazard statements

H225 - Highly flammable liquid and vapor. H319 - Causes serious eye irritation. H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H360 - May damage fertility or the unborn child. H341 - Suspected of causing genetic defects. H351 - Suspected of causing cancer. H370 - Causes damage to organs. (thymus) H336 - May cause drowsiness or dizziness. H372 - Causes damage to organs through prolonged or repeated exposure. (immune system, kidneys, liver)

Prevention

P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P280 - Wear protective gloves. Wear protective clothing. Wear eye or face protection. P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P271 - Use only outdoors or in a well-ventilated area. P260 - Do not breathe vapor. P270 - Do not eat, drink or smoke when using this product. P264 - Wash hands thoroughly after handling. P272 - Contaminated work clothing should not be allowed out of the workplace.

Response

P314 - Get medical attention if you feel unwell. P308 + P311 - IF exposed or concerned: Call a POISON CENTER or physician. P304 + P340 + P312 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER or physician if you feel unwell. P303 + P361 + P353 - IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. P302 + P352 + P362 + P364 - IF ON SKIN: Wash with plenty of soap and water. Take off contaminated clothing and wash it before reuse. P333 + P313 - If skin irritation or rash occurs: Get medical attention. P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337 + P313 - If eye irritation persists: Get medical attention.

Storage

P405 - Store locked up.

Disposal

P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.

Other hazards which do not result in classification

Prolonged or repeated contact may dry skin and cause irritation. Repeated exposure to high vapor concentrations may cause irritation of the respiratory system and permanent brain and nervous system damage. Inhalation of vapor/aerosol concentrations above the recommended exposure limits causes headaches, drowsiness and nausea and may lead to unconsciousness or death. Emits toxic fumes when heated. See toxicological information (Section 11)

2.1 Classification of the substance or mixture

FLAMMABLE LIQUIDS - Category 2 substance or mixture SKIN IRRITATION - Category 2 EYE IRRITATION - Category 2A SKIN SENSITIZATION - Category 1 GERM CELL MUTAGENICITY - Category 2 CARCINOGENICITY - Category 2 TOXIC TO REPRODUCTION (Fertility) - Category 1B TOXIC TO REPRODUCTION (Unborn child) - Category 1B SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) (thymus) - Category 1 SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) (Narcotic effects) - Category 3 SPECIFIC TARGET ORGAN TOXICITY (REPEATED EXPOSURE) (immune system, kidneys, liver) - Category 1 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 35.7% (Oral), 46.6% (Dermal), 48.2% (Inhalation)